1.53
Biorestorative Therapies Inc stock is traded at $1.53, with a volume of 23,781.
It is up +1.34% in the last 24 hours and down -7.83% over the past month.
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
See More
Previous Close:
$1.5098
Open:
$1.505
24h Volume:
23,781
Relative Volume:
0.20
Market Cap:
$12.21M
Revenue:
$149.50K
Net Income/Loss:
$-6.96M
P/E Ratio:
-1.125
EPS:
-1.36
Net Cash Flow:
$-6.37M
1W Performance:
+0.66%
1M Performance:
-7.83%
6M Performance:
-15.00%
1Y Performance:
-7.83%
Biorestorative Therapies Inc Stock (BRTX) Company Profile
Name
Biorestorative Therapies Inc
Sector
Industry
Phone
(631) 760-8100
Address
40 MARCUS DRIVE, MELVILLE
Compare BRTX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
BRTX
Biorestorative Therapies Inc
|
1.53 | 12.29M | 149.50K | -6.96M | -6.37M | -1.36 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Biorestorative Therapies Inc Stock (BRTX) Latest News
Using AI based signals to follow BioRestorative Therapies Inc.Market Performance Summary & Weekly Setup with High ROI Potential - Newser
Pattern recognition hints at BioRestorative Therapies Inc. upsideInflation Watch & Safe Entry Point Identification - Newser
Predicting BioRestorative Therapies Inc. trend using moving averages2025 Investor Takeaways & AI Enhanced Trading Signals - Newser
What earnings revisions data tells us about BioRestorative Therapies Inc.2025 Major Catalysts & Real-Time Price Movement Reports - Newser
Using Ichimoku Cloud for BioRestorative Therapies Inc. technicalsJuly 2025 Snapshot & Free Technical Pattern Based Buy Signals - Newser
What candlestick patterns are forming on BioRestorative Therapies Inc.2025 Dividend Review & Smart Allocation Stock Tips - Newser
Tick level data insight on BioRestorative Therapies Inc. volatility2025 Risk Factors & Smart Money Movement Alerts - Newser
How high can BioRestorative Therapies Inc. stock goLong Setup & Accurate Buy Signal Alerts - Newser
Tools to assess BioRestorative Therapies Inc.’s risk profileQuarterly Portfolio Report & Verified Momentum Watchlists - Newser
Visualizing BioRestorative Therapies Inc. stock with heatmaps2025 Growth vs Value & High Accuracy Buy Signal Tips - Newser
Published on: 2025-08-19 21:09:47 - 선데이타임즈
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Up 1.3% – Should You Buy? - Defense World
Published on: 2025-08-19 00:46:49 - Newser
Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Beats Revenue Estimates - MSN
Published on: 2025-08-19 05:01:08 - classian.co.kr
Are Medical Stocks Lagging Black Diamond Therapeutics (BDTX) This Year? - Yahoo Finance
BioRestorative Therapies rises on expanded tissue license from NY state health department - MSN
What does recent volatility data suggest for BioRestorative Therapies Inc.Quarterly Investment Review & Low Drawdown Momentum Ideas - Newser
Published on: 2025-08-17 05:16:04 - Newser
Trading Bots Trigger Alerts on BioRestorative Therapies Inc. ActivityEarnings Beat & Smart Allocation Stock Reports - metal.it
Key resistance and support levels for BioRestorative Therapies Inc.July 2025 Drop Watch & Long Hold Capital Preservation Tips - Newser
Forecasting BioRestorative Therapies Inc. price range with options dataPortfolio Risk Summary & Safe Capital Allocation Plans - Newser
Applying big data sentiment scoring on BioRestorative Therapies Inc.Quarterly Performance Summary & High Accuracy Swing Entry Alerts - Newser
Published on: 2025-08-17 11:59:07 - kangso.co.kr
Is BioRestorative Therapies Inc. trading at a discountEntry Point & Real-Time Market Sentiment Reports - newsyoung.net
Advanced analytics toolkit walkthrough for BioRestorative Therapies Inc.Quarterly Profit Report & Free Weekly Watchlist of Top Performers - Newser
Can technical indicators confirm BioRestorative Therapies Inc.’s reversalJuly 2025 Analyst Calls & Intraday High Probability Setup Alerts - Newser
Roth Capital Issues Positive Estimate for BRTX Earnings - Defense World
Is now a turning point for BioRestorative Therapies Inc.Market Sentiment Summary & Reliable Entry Point Alerts - Newser
Candlestick signals on BioRestorative Therapies Inc. stock todayDividend Hike & AI Driven Stock Reports - Newser
Will BioRestorative Therapies Inc. see short term momentumQuarterly Profit Summary & Weekly Top Performers Watchlists - Newser
What indicators show strength in BioRestorative Therapies Inc.July 2025 Market Mood & High Yield Equity Trading Tips - Newser
Real time breakdown of BioRestorative Therapies Inc. stock performanceTrade Signal Summary & Safe Entry Zone Identification - Newser
BioRestorative Therapies Updates Corporate Presentation - TipRanks
Combining machine learning predictions for BioRestorative Therapies Inc.Recession Risk & Technical Pattern Recognition Alerts - Newser
Positive Outlook for BioRestorative Therapies: Strong Financials and Promising Clinical Developments Drive Buy Rating - TipRanks
BioRestorative Therapies Reports Strong Q2 Growth Amid Challenges - MSN
Biorestorative Therapies shares rise 3.40% intraday after reporting Q2 2025 financial results and clinical program milestones. - AInvest
BioRestorative Therapies earnings beat by $0.08, revenue fell short of estimates - Investing.com Nigeria
Disc Medicine,Inc. shares rise 2.40% intraday after BioRestorative Therapies reported Q2 2025 financial results and clinical program milestones. - AInvest
Technical signs of recovery in BioRestorative Therapies Inc.Quarterly Trade Report & Community Consensus Trade Alerts - Newser
BioRestorative Therapies, Inc. (NASDAQ:BRTX) Q2 2025 Earnings Call Transcript - Insider Monkey
How BioRestorative Therapies Inc. stock performs during market volatilityQuarterly Profit Review & Verified Momentum Watchlists - Newser
Published on: 2025-08-13 05:10:04 - Newser
BioRestorative Therapies Inc (BRTX) Q2 2025 Earnings Call Highlights: Revenue Surge Amid ... By GuruFocus - Investing.com Canada
Biorestorative Therapies Inc Stock (BRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):